Search Results - "Breast cancer (Tokyo, Japan)"

CircRNA: a novel type of biomarker for cancer by Zhang, He-da, Jiang, Lin-hong, Sun, Da-wei, Hou, Jun-chen, Ji, Zhen-ling

“…Circular RNAs (circRNAs) are a class of long, non-coding RNAs molecules that shape a covalently closed continuous loop which have no 5′–3′ polarity and contain…”
Get full text

lncRNA TCL6 correlates with immune cell infiltration and indicates worse survival in breast cancer by Zhang, Yaqiong, Li, Zhaoyun, Chen, Meifang, Chen, Hanjun, Zhong, Qianyi, Liang, Lingzhi, Li, Bo

“…Background Long non-coding RNA (lncRNA) T-cell leukemia/lymphoma 6 (TCL6) has been reported as a potential tumor suppressor. However, its expression and…”
Get full text

Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis by Yoshida, Reiko

“…Breast cancer is a common cancer affecting a large number of patients. Notably, 5–10% of all breast cancer patients are genetically predisposed to cancers…”
Get full text

The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR status by Horisawa, Nanae, Adachi, Yayoi, Takatsuka, Daiki, Nozawa, Kazuki, Endo, Yuka, Ozaki, Yuri, Sugino, Kayoko, Kataoka, Ayumi, Kotani, Haruru, Yoshimura, Akiyo, Hattori, Masaya, Sawaki, Masataka, Iwata, Hiroji

“…Purpose The DESTINY-Breast04 clinical trial is currently investigating whether trastuzumab deruxtecan (T-DXd) is effective in HER2-low as well as HER2-positive…”
Get full text

Prevalence of anxiety among breast cancer patients: a systematic review and meta-analysis by Hashemi, Seyed-Mehdi, Rafiemanesh, Hosein, Aghamohammadi, Tayebe, Badakhsh, Mahin, Amirshahi, Mehrbanoo, Sari, Mahdieh, Behnamfar, Niaz, Roudini, Kamran

“…This study aimed to determine the prevalence of anxiety among breast cancer patients. In April 2019, three electronic databases (PubMed, Web of Science, and…”
Get full text

An overview of mammographic density and its association with breast cancer by Nazari, Shayan Shaghayeq, Mukherjee, Pinku

“…In 2017, breast cancer became the most commonly diagnosed cancer among women in the US. After lung cancer, breast cancer is the leading cause of cancer-related…”
Get full text

Neoadjuvant talazoparib in patients with germline BRCA1/2 mutation-positive, early-stage triple-negative breast cancer: exploration of tumor BRCA mutational status by Telli, Melinda L., Litton, Jennifer K., Beck, J. Thaddeus, Jones, Jason M., Andersen, Jay, Mina, Lida A., Brig, Raymond, Danso, Michael, Yuan, Yuan, Symmans, William F., Hopkins, Julia F., Albacker, Lee A., Abbattista, Antonello, Noonan, Kay, Mata, Marielena, Laird, A. Douglas, Blum, Joanne L.

“…Background Talazoparib monotherapy in patients with germline BRCA -mutated, early-stage triple-negative breast cancer (TNBC) showed activity in the neoadjuvant…”
Get full text

Prognosis of isolated locoregional recurrence after early breast cancer with immediate breast reconstruction surgery: a retrospective multi‑institutional study by Seki, Hirohito, Ogiya, Akiko, Nagura, Naomi, Shimo, Ayaka, Narui, Kazutaka, Sasada, Shinsuke, Ishitobi, Makoto, Nogi, Hiroko, Kondo, Naoto, Sakurai, Teruhisa, Yamauchi, Chikako, Mori, Hiroki, Saiga, Miho, Niikura, Naoki, Shien, Tadahiko

“…Background The prognosis in patients with breast cancer with isolated locoregional recurrence (ILRR) without simultaneous distant metastases after immediate…”
Get full text

Advances in personalized cancer immunotherapy by Kakimi, Kazuhiro, Karasaki, Takahiro, Matsushita, Hirokazu, Sugie, Tomoharu

“…There are currently three major approaches to T cell-based cancer immunotherapy, namely, active vaccination, adoptive cell transfer therapy and immune…”
Get full text

Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a multicenter retrospective study (ROSET-BM) by Nakayama, Takahiro, Niikura, Naoki, Yamanaka, Takashi, Yamamoto, Mitsugu, Matsuura, Kazuo, Inoue, Kenichi, Takahara, Sachiko, Nomura, Hironori, Kita, Shosuke, Yamaguchi, Miki, Aruga, Tomoyuki, Shibata, Nobuhiro, Shimomura, Akihiko, Ozaki, Yuri, Sakai, Shuji, Takiguchi, Daisuke, Takata, Takehiko, Bastanfard, Armin, Shiosakai, Kazuhito, Tsurutani, Junji

“…We provide updated results (median follow-up duration: 20.4 months) of a retrospective study on the effectiveness of trastuzumab deruxtecan (T-DXd) in patients…”
Get full text

Survival in patients with rheumatoid arthritis and early breast cancer treated with tumor necrosis factor inhibitors by Ruiz, Juan I., Lei, Xiudong, Chi-Fang, Wu, Giordano, Sharon H., Zhao, Hui, Rajan, Suja S., Lin, Heather, Suarez-Almazor, Maria E.

“…Background There have been concerns about the use of tumor necrosis factor inhibitors (TNFi) for autoimmune disease in patients with recently diagnosed cancer…”
Get full text

Predictive factors for response to neoadjuvant chemotherapy: inflammatory and immune markers in triple-negative breast cancer by Kusama, Hiroki, Kittaka, Nobuyoshi, Soma, Ai, Taniguchi, Azusa, Kanaoka, Haruka, Nakajima, Satomi, Oyama, Yuri, Seto, Yukiko, Okuno, Jun, Watanabe, Noriyuki, Matsui, Saki, Nishio, Minako, Fujisawa, Fumie, Honma, Keiichiro, Tamaki, Yasuhiro, Nakayama, Takahiro

“…Background Tumor-infiltrating lymphocytes (TILs) predict response to neoadjuvant chemotherapy (NAC) in triple-negative breast cancer (TNBC) patients. However,…”
Get full text

Breast cancer incidence, mortality and mortality-to-incidence ratio (MIR) are associated with human development, 1990–2016: evidence from Global Burden of Disease Study 2016 by Sharma, Rajesh

“…Objective To examine breast cancer burden in females using incidence, mortality and mortality-to-incidence ratio (MIR) and its association with human…”
Get full text

Case series of Li-Fraumeni syndrome: carcinogenic mechanisms in breast cancer with TP53 pathogenic variant carriers by Hosonaga, Mari, Habano, Eri, Arakawa, Hiromi, Kaneko, Keika, Nakajima, Takeshi, Hayashi, Naomi, Fukada, Ippei, Nakamura, Akira, Haruyama, Yurie, Maeda, Tetsuyo, Inari, Hitoshi, Kobayashi, Takayuki, Nakashima, Eri, Ueno, Takayuki, Takano, Toshimi, Takahashi, Shunji, Ohno, Shinji, Ueki, Arisa

“…Background Li-Fraumeni syndrome (LFS), a hereditary condition attributed to TP53 pathogenic variants,(PV), is associated with high risks for various malignant…”
Get full text

Increasing survivors of anthracycline-related cardiomyopathy with breast cancer in trastuzumab era: thirty-one-year trends in a Japanese Community by Watanabe, Mitsuhiro, Fujiki, Shinya, Okura, Yuji, Toshikawa, Chie, Ikarashi, Mayuko, Kanbayashi, Chizuko, Kaneko, Koji, Kikuchi, Akira, Sakata, Eiko, Tsuchida, Keiichi, Ozaki, Kazuyuki, Moro, Kazuki, Kubota, Naoki, Kashimura, Takeshi, Moriyama, Masato, Sato, Nobuaki, Tanabe, Naohito, Koyama, Yu, Wakai, Toshifumi, Saijo, Yasuo, Inomata, Takayuki

“…Background Trastuzumab has improved breast cancer (BC) prognosis and reduced anthracycline use. However, the characteristic changes of anthracycline-related…”
Get full text

Uptake of ultra-hypofractionated radiation therapy following breast-conserving surgery among patients with early-stage breast cancer: a multi-institutional questionnaire survey by Uezono, Haruka, Onoe, Tsuyoshi, Shikama, Naoto, Ono, Yuka, Hirata, Hidenari, Ito, Yoshinori, Yasuda, Koichi, Imano, Nobuki, Kikuchi, Koyo, Kashihara, Tairo, Kawamoto, Terufumi, Nakamura, Naoki

“…Background In patients with early-stage breast cancer following breast surgery, ultra-hypofractionated (UHF) breast/chest wall radiation therapy (RT) has been…”
Get full text

Comparison of locoregional recurrence risk among nipple-sparing mastectomy, skin-sparing mastectomy, and simple mastectomy in patients with ductal carcinoma in situ: a single-center study by Nashimoto, Mika, Asano, Yuko, Matsui, Hiroki, Machida, Youichi, Hoshi, Kazuei, Kurosumi, Masafumi, Fukuma, Eisuke

“…Background In invasive breast cancer, there are no differences among the mid- and long-term oncological safety results of nipple-sparing mastectomy (NSM),…”
Get full text

Reply to the Letter to the editor “Does axillary lymph node recurrence breast cancer subtype information matter for prognosis estimation?” by Seki, Hirohito, Sasada, Shinsuke, Shien, Tadahiko

Get full text

High-risk pathogenic germline variants in blood relatives of BRCA1/2 negative probands by Yoshida, Reiko, Kaneyasu, Tomoko, Ueki, Arisa, Yamauchi, Hideko, Ohsumi, Shozo, Ohno, Shinji, Aoki, Daisuke, Baba, Shinichi, Kawano, Junko, Matsumoto, Naomichi, Nagasaki, Masao, Ueno, Takayuki, Inari, Hitoshi, Kobayashi, Yusuke, Takei, Junko, Gotoh, Osamu, Nishi, Mitsuyo, Okamura, Miki, Kaneko, Keika, Okawa, Megumi, Suzuki, Misato, Amino, Sayuri, Inuzuka, Mayuko, Noda, Tetsuo, Mori, Seiichi, Nakamura, Seigo

“…Background Tailored, preventive cancer care requires the identification of pathogenic germline variants (PGVs) among potentially at-risk blood relatives (BRs)…”
Get full text

Does axillary lymph node recurrence breast cancer subtype information matter for prognosis estimation? by Altundag, Kadri

Get full text